Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

DaVita

DVA Health Care Unknown Updated July 11, 2026
$232.51
52W $101.00 – $239.64
56/100
$14.73B
18.8
0.88
Price History (6M)
AI Committee Verdict
Watch
Conviction: Contested · 50% agreement · 6 analysts
-37.6%
100%
Executive Summary
7 analysts weighed in with 43% agreement on a bullish lean. Portfolio Manager: Portfolio position concentration is currently healthy. Risk Analyst: High leverage (debt-to-equity 77.99) amplifies downside in a stress scenario. Overall recommendation: WATCH.
Bull & Bear Case
Bull Case
  • RSI at or above 70 signals overbought conditions — bearish entry bias.
  • Positive MACD histogram signals bullish momentum.
  • Daily trend: uptrend.
  • Weekly trend: uptrend.
  • Daily and weekly trends are both bullish — multi-timeframe alignment, highest confidence.
Bear Case
  • RSI is overbought at 72.8 — momentum may be exhausted.
AI Investment Committee
Committee Consensus As of July 11, 2026
Overall Committee Score
56/100
Agreement
50%
Analysts
6
Conviction
Contested
Value Analyst neutral
50 / 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 181.2% shows genuine earnings power backing the valuation
− Price-to-book of 101.2x prices in significant intangible value
Growth Analyst bearish
38 / 100 · Moderate confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst neutral
57 / 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− RSI at 73 is in overbought territory
Risk Analyst bearish
32 / 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 77.99) amplifies downside in a stress scenario
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
64 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 18 articles, 14d)
Portfolio Manager bullish
75 / 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Open Full Terminal →
Technical Analysis
RSI (14)
72.8
Overbought
MACD Histogram
0.444
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.81
Inside Bands
Price vs Moving Averages
EMA 9
$228.29 Above
EMA 21
$219.24 Above
EMA 50
$201.87 Above
EMA 200
$163.39 Above
Fundamental Analysis
Valuation
42
Growth
42
Profitability
51
Financial Health
20
Valuation
P/E Ratio 18.8×
P/B Ratio 101.25×
PEG Ratio
Dividend Yield
52W High $239.64
52W Low $101.00
Quality & Growth
ROE 18122.0%
ROA 446.0%
Gross Margin 3245.0%
Operating Margin 1498.0%
Revenue Growth YoY +668.0%
Debt / Equity 77.99
AI Fundamental Assessment
P/E ratio of 18.8 (inexpensive relative to a 15-40x range); Price-to-book of 101.2x; Revenue growth (YoY) of 6.7%; EPS growth (YoY) of 6.6%; Return on equity of 181.2%; Return on assets of 4.5%; Net margin of 5.7%; Gross margin of 32.5%; Current ratio of 1.29 (tight short-term liquidity); Debt-to-equity of 77.99; Most recent quarter beat estimates by 22.6%; 2 consecutive earnings beats; EPS growth decelerating (+66.7% -> -15.6% QoQ); Analyst estimates falling over recent quarters
Key Risks
  • RSI is overbought at 72.8 — momentum may be exhausted.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full DVA Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime